Contributor Page
Spriggs & Hollingsworth
 
Email  |  Articles
Contact Details
Tel: +1 202 8985800
Fax: +1 202 6821639
1350 I Street N.W.
Washington, DC
20005
United States
By Eric Lasker
On January 24, 2006, the Food and Drug Administration (FDA) forcefully reiterated its position that state tort law claims based on alleged inadequate warnings in FDA-approved prescription drug labels are preempted by federal law.
By Marc Mayerson
In his seminal book published more than 75 years ago entitled Business Interruption Insurance (Philadelphia 1930), C.M. Kahler wrote that "[u]nfortunately the development of an adequate system of business interruption insurance has been hampered by the fact that it has always been considered as a part of the direct damage insurance of the particular hazard."